Patient no. | Stage | Bulky disease | Histopathological subtype | Localization of leading lesion | Response assessment at interim | Follow-up | ||
---|---|---|---|---|---|---|---|---|
iCIM | iPET | ΔSUVmax (%) | ||||||
1 | III | B | lymphoblastic | Nodal | CRu | + | 88.1 | CR |
2 | II | - | DLBCL | Nodal | PR | - | 92.2 | CR |
3 | IV | - | DLBCL | Bone/bone marrow | SD | - | 94.5 | CR |
4 | II | - | Follicular grade 2 | Nodal | CR | + | * | CR |
5 | IV | B | DLBCL | Nodal | CRu | + | 60.8 | CR |
6 | IV | B | DLBCL | Nodal | CRu | + | * | CR |
7 | II | - | Burkitt | Nodal | CR | - | 97.2 | CR |
8 | III | - | ALCL | Nodal | CR | + | 47.8 | Relapse |
9 | I | B | Burkitt | Nodal | CRu | + | 91.2 | CR |
10 | IV | B | Burkitt | Nodal | CR | - | 95.2 | CR |
11 | IV | - | Burkitt | Nodal | CRu | + | 90.5 | Relapse |
12 | II | B | ALCL | Nodal | CRu | - | 95.8 | CR |
13 | IV | - | Lymphoblastic | Nodal | PR | + | 88.5 | Relapse |
14 | III | - | ALCL | Nodal | CRu | + | 34.1 | CR |
15 | III | B | Burkitt | Extra nodal (stomach) | CR | + | 50.7 | CR |
16 | IV | B | Burkitt | Nodal | CR | + | 92.5 | CR |
17 | I | - | DLBCL | Nodal | CR | - | 95.8 | Relapse |
18 | IV | - | Burkitt | Nodal | CR | - | 93.5 | CR |